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Objective  To investigate alterations in the expression of the main regulators of neuronal survival and death related 
to astrocytes and neuronal cells in the brain in a mouse model of spinal cord injury (SCI). 
Methods  Eight-week-old male imprinting control region mice (n=36; 30–35 g) were used in this study and 
randomly assigned to two groups: the naïve control group (n=18) and SCI group (n=18). The mice in both groups 
were randomly allocated to the following three time points: 3 days, 1 week, and 2 weeks (n=6 each). The expression 
levels of regulators such as brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor 
(GDNF), nerve growth factor (NGF), histone deacetylase 1 (HDAC1), and methyl-CpG-binding protein 2 (MeCP 
2) in the brain were evaluated following thoracic contusive SCI. In addition, the number of neuronal cells in 
the motor cortex (M1 and M2 areas) and the number of astrocytes in the hippocampus were determined by 
immunohistochemistry. 
Results  BDNF expression was significantly elevated at 2 weeks after injury (p=0.024). The GDNF level was 
significantly elevated at 3 days (p=0.042). The expression of HDAC1 was significantly elevated at 1 week (p=0.026). 
Following SCI, compared with the control the number of NeuN-positive cells in the M1 and M2 areas gradually 
and consistently decreased at 2 weeks after injury. In contrast, the number of astrocytes was significantly increased 
at 1 week (p=0.029).
Conclusion  These results demonstrate that the upregulation of BDNF, GDNF and HDAC1 might play on important 
role in brain reorganization after SCI.
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INTRODUCTION
Anatomical and functional changes after spinal cord 
injury (SCI) include both retrograde and anterograde 
degeneration [1,2]. SCI results in removal of supraspi-
nal input to the spinal sensory and motor networks, and 
thus results in permanent and severe sensory and motor 
dysfunction after injury. However, some degree of func-
tional recovery can be observed after SCI [3]. Since reor-
ganization of injured axons is limited in the mature CNS, 
spontaneous functional recovery appears to be regulated 
by reorganization of the spared nervous system. This 
secondary remodeling occurs at multiple levels of the 
axis, including the site of SCI, supraspinal tracts, brain-
stem, and brain hemisphere [4]. Greater structural and 
functional changes are evident after large-scale injuries 
such as SCI or limb amputation [5,6]. PET and EEG in SCI 
patients have shown reorganization related to functional 
recovery and changes in subcortical or cortical activation 
[7-9].
A few studies have reported changes in the expres-
sion of the prohormone convertase, neurotrophins, and 
related receptors in the injured site following SCI [10]. 
Epigenetic regulators—histone deacetylase (HDAC) fam-
ily and methyl-CpG-binding protein (MeCP)—have been 
shown to play an important role in neurodegenerative 
diseases and neurological conditions, such as traumatic 
brain injury (TBI) and stroke [11,12]. A recent study 
reported that the degree and pattern of changes in the 
brain after SCI were similar to those associated with the 
chronic neurodegeneration and cognitive deficits ob-
served after TBI in rats [13]. However, since experimental 
animal studies following SCI have focused on the spinal 
cord and the pathway, there is little information on the 
pathophysiologic alterations in the brain level after SCI. A 
recent experimental study revealed that isolated thoracic 
SCI causes chronic diffuse inflammation in the brain by 
increasing numbers of reactive microglial cells, and el-
evating the expression of microglial cell-related markers 
[14]. However, although diverse changes in and roles of 
astrocytes after SCI have been reported, no study to date 
has addressed their pattern of changes specifically at the 
brain level. 
Therefore, we examined the pattern of change in the ex-
pression of the main survival- and death-related regula-
tors of neuronal cells and astrocytes in the brain after SCI.
MATERIALS AND METHODS
Experimental animals
Eight-week-old male imprinting control region mice 
(n=36; 30–35 g; OrientBio, Seongnam, Korea) were used 
in this study. All animal care, interventions and euthana-
sia procedures were in accordance with the National In-
stitutes of Health Guide for the Care and Use of Laborato-
ry Animals and guidelines approved by the Animal Care 
and Use Committees of Department of Rehabilitation 
Medicine, Yonsei University Wonju College of Medicine. 
At the beginning of the experiment, animals were ran-
domly assigned to two groups: the naïve control group 
(n=18) and SCI group (n=18). The mice in the SCI and 
control group were randomly allocated to the following 
three time points: day 3, week 1, and week 2 (n=6 each). 
At each time point, three of the mice were subjected to 
Western blot for molecular analysis and the other three 
were evaluated by means of immunochemistry.
Moderate spinal cord contusion
The prescribed animals underwent a contusive impact 
SCI induced using an Infinite Horizons device (Preci-
sion Systems and Instrumentation, Lexington, NY, USA). 
Animals were anesthetized with a mixture of ketamine 
and xylazine (0.05 mL/kg) and absence of blink and with-
drawal reflexes were ensured. During surgery, the mice 
were kept on a homeothermic blanket system (Harvard 
Apparatus Ltd., Kent, UK) to maintain the body tem-
perature at 37.0oC±0.5oC as measured by a rectal probe. 
Following anesthesia, a vertical incision was made along 
the low thoracic vertebra and the superficial muscle and 
skin retracted. A laminectomy performed at thoracic ver-
tebra T10 exposed the dorsal surface of the spinal cord 
without disrupting the dura mater. Stabilization clamps 
were placed around the vertebrae at T9 and L2 to support 
the column during impact. Injury was induced using the 
tip of the impactor probe, which transduces a moderate 
of 50 kdyne. Feedback from the Infinite Horizons device, 
including the actual impact force, cord displacement, 
graph of time versus force, and graph of time versus dis-
placement, were recorded for each animal. After SCI, the 
muscles were sutured in layers with 5-0 chromic gut, and 
skin was closed with 7 mm wound clips. After surgery, 
mice were allowed to recover in a warmed cage with 
water and food easily accessible. Gentamicin (5 mg/kg, 
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intramuscular; Abbott Laboratories, North Chicago, IL, 
USA) was administered immediately post-surgery. Ani-
mals were doubly housed in Mouse Houses for the dura-
tion of the study. Postoperative care consisted of manual 
bladder expression twice per day until mice recovered 
some bladder expression, then once per day for the dura-
tion of the study. 
The mice were maintained for 2 weeks after injury with 
all brains collected at 3 days, 1 and 2 weeks, for HDAC 
and MeCP2 related protein, brain-derived neurotrophic 
factor (BDNF), glial cell line-derived neurotrophic factor 
(GDNF) and nerve growth factor (NGF) analysis. 
Immunohistochemistry
The mice (n=3) in each group were deeply anesthetized 
as described above, and the thorax was opened. The mice 
were perfused transcardially with 100 mL of 0.9% sodium 
chloride, then with 200 mL of 4% paraformaldehyde in 
0.1 M phosphate buffer (PB, pH 7.4). The brains were 
carefully removed from the skull, fixed for 12 hours in the 
same fixative, and infiltrated with 30% sucrose solution 
at 4oC until they sank. The brains were then placed on 
a brain blocker (David Kopf Instruments, Tujunga, CA, 
USA). The blocker was then rapidly frozen in 2-methylbu-
tane, chilled on dry ice, and mounted in Tissue-Tek OCT 
compound (Sakura Finetechnical Co., Tokyo, Japan). Se-
rial coronal sections 24 μm in thickness were obtained 
using a cryostat microtome (Leica Microsystems Inc., 
Wetzlar, Germany) and were distributed sequentially into 
a set of 12 tissue wells containing 0.1 M PB. After a brief 
wash with 0.1 M PB, the brain sections were transferred 
to another set of 12 tissue wells containing cryoprotection 
solution and then stored in a freezer at a temperature 
below –20oC until use. The sections were washed three 
times with 0.1 M PBS and treated with 3% hydrogen per-
oxide for 15 minutes to suppress endogenous peroxidase 
activity. After washing with 0.1 M PBS, the sections were 
treated for 1 hour with 5% normal serum obtained from 
the same host species to reduce non-specific binding and 
were then incubated with rabbit anti-NeuN monoclonal 
antibody (1:400; Chemicon, Temecula, CA, USA) and 
mouse anti-GFAP (1:400; Abcam, Cambridge, UK) diluted 
in 0.1 M PBST overnight at 4oC. Sections were washed in 
PBS and incubated for 1 h with goat anti-rabbit IgG con-
jugated Alexa 595 and goat anti-mouse IgG conjugated 
Alexa 488 (1:400; Santa Cruz Biotech, Santa Cruz, CA, 
USA) for neurons and astrocytes. The numbers of NeuN-
positive cells and GFAP-positive cells were counted on 
coronal sections stained with NeuN and GFAP. Three of 
12 sets of samples were randomly chosen from each ani-
mal and mounted on gelatin slides. Regions of interest 
(motor cortex and hippocampus) related to motor con-
trol and cognitive function were identified [14]. 
Western blot analysis
To identify the neuromodulators associated with neuro-
nal cell development, growth, survival and apoptosis, the 
expression of three specific neurotrophic factors (DNF, 
NGF and GDNF) in the whole brain was investigated by 
Western blotting.
To compare the expression levels of epigenetic regula-
tors and neurotrophic factors, mouse brains were lysed 
in 500 μL of cold RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% 
Triton X-100, 150 mM NaCl, 0.1% sodium dodecyl sulfate 
[SDS], and 1% sodium deoxycholate) with a protease 
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA). 
Tissue lysate was centrifuged at 13,000 g for 15 minutes 
at 4oC. The supernatant was harvested, and protein con-
centration was analyzed using a Quant-iT protein assay 
kit (Molecular Probes, Eugene, OR, USA). For electropho-
resis, 50 μg of protein were dissolved in sample buffer (60 
mM Tris-HCl, pH 6.8, 14.4 mM β-mercaptoethanol, 25% 
glycerol, 2% SDS, and 0.1% bromophenol blue), boiled 
for 10 minutes and separated on a 10% SDS reducing gel. 
Separated proteins were transferred onto polyvinylidene 
difluoride membranes (Invitrogen, Carlsbad, CA, USA) 
using a trans-blot system. Blots were blocked for 1 hour 
in Tris-buffered saline (TBS; 10 mM Tris-HCl, pH 7.5, 150 
mM NaCl) containing 5% nonfat dry milk at room tem-
perature, washed three times with TBS and incubated 
at 4oC overnight with an anti-rabbit polyclonal HDAC1 
(1:1000, Santa Cruz Biotech), anti-goat polyclonal MeCP2 
(1:1000, Santa Cruz Biotech), anti-mouse monoclonal 
BDNF (1:1000, Abcam), anti-rabbit polyclonal NGF 
(1:1000, Abcam), anti-mouse GDNF (1:1000, Abcam), and 
anti-GAPDH (1:3000, Cell signaling, Boston, MA, USA) 
antibody in TBST (10 mM Tris, pH 7.5, 150 mM NaCl, and 
0.02% Tween 20) containing 5% nonfat dry milk. On the 
next day, blots were washed three times with TBST and 
incubated for 1 hour with horseradish peroxidase-conju-
gated secondary antibodies (1:3000, Santa Cruz Biotech) 
in TBST containing 3% nonfat dry milk at room tempera-
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ture. After washing three times with TBST, proteins were 
visualized using an ECL detection system (Amersham 
Pharmacia Biotech, Piscataway, NJ, USA).
Image analysis
Light photomicrographic images were acquired using 
a Nikon Optiphot microscope (Nikon Inc., Tokyo, Japan) 
fitted with a Nikon digital camera (DXM1200), using the 
Nikon ACT-1 image capture software (ver. 2.2). NeuN- 
and GFAP-positive cells in the M1, M2 and hippocampus 
were measured using the MetaMorph Imaging System 
(Molecular Device, Sunnyvale, CA, USA). The images 
were imported into Adobe Photoshop (ver. 7.0, Adobe 
Systems Inc., San Jose, CA, USA) and were adjusted for 
brightness and contrast to optimize the clarity.
Statistical analysis
Statistical analysis was performed using the Mann-
Whitney U test (GraphPad Prism Software, San Diego, 
CA, USA). The data are expressed as mean±standard er-
ror of the mean. The significance level was set at 5%, and 
all statistical analyses were performed using the SPSS 
software (SPSS Inc., Chicago, IL, USA).
RESULTS
Changes in the expression of neurotrophic factors 
following SCI 
Expression of BDNF was significantly elevated in the 
SCI group compared with that in the control group at 2 
weeks after SCI (n=3, p=0.024). However, expression of 
BDNF was not significantly different compared with that 
of the control group at 3 days and 1 week after SCI (Fig. 
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Fig. 1. Neurotrophic factor expression by Western blotting analysis. (A) Representative expressions of BDNF, NGF, and 
GDNF in the brain after contusion of the spinal cord in mice. (B) BDNF significantly elevated compared with those 
of control group at 2 weeks after SCI (*p<0.05). (C) Representative expressions of NGF in brain after contusion of the 
spinal cord in mice. NGF elevated compared with those of control group at 1 and 2 weeks and decreased at 3 days; 
however, the differences were not significant. (D) Representative GDNF expression in the brain after contusion of the 
spinal cord in mice. GDNF expression was significantly elevated compared with the control group at 3 days (*p<0.05). 
Data are plotted as mean±standard error of the mean. BDNF, brain-derived neurotrophic factor; NGF, nerve growth 
factor; GDNF, glial cell line-derived neurotrophic factor; SCI, spinal cord injury; GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase. *p<0.05 indicates values significantly different from those of SCI and the control group.
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1A, 1B). The level of NGF was elevated in the SCI group 
at 1 week and 2 weeks and decreased at 3 days compared 
with that of the control group after SCI; however, the dif-
ferences were not significant (Fig. 1A, 1C). The level of 
GDNF was significantly elevated in the SCI group com-
pared with that in the control group at 3 days after SCI 
(n=3, p=0.042). The expression of GDNF was elevated at 
1 and 2 weeks compared with the control group after SCI; 
however, the differences were not significant (Fig. 1A, 
1D).
Changes in the expression of epigenetic regulators 
following SCI 
The expression of HDAC1 was significantly elevated at 
1 week in the SCI group compared with the control group 
(n=3, p=0.026). The expression of HDAC1 at 3 days and 
2 weeks in the SCI group was not significantly different 
compared with those in the control group (Fig. 2A, 2B). 
However, the expression of MeCP2 was not different in 
the SCI group compared with the control group (Fig. 2A, 
2C).
SCI mediated change in the number of neurons and 
astrocytes in the motor cortex and hippocampus
Following SCI, compared to the control, the number 
of NeuN-positive cells in the M1 and M2 areas gradu-
ally and consistently decreased 2 weeks after injury. 
The number of surviving NeuN-positive cells in the M1 
and M2 areas was significantly lower in mice with a SCI 
(634±100.2) than in the normal controls (1,014±82.65) at 
1 week after injury (n=3, p=0.005) (Fig. 3). The number 
of surviving NeuN-positive cells in the M1 and M2 areas 
was significantly lower in mice with a SCI (462.2±37.42) 
than in the normal controls (1,014±82.65) at 2 weeks after 
injury (n=3, p<0.001) (Fig. 3). In contrast, the number 
of GFAP-positive astrocytes in the hippocampus signifi-
cantly increased in SCI mice (100,834±11,423) compared 
to control mice (62,246±4,253) at 1 week after SCI (n=3, 
p=0.029). However, the difference in the number of 
GFAP-positive astrocytes was not significant compared 
with the control group at 2 weeks after SCI (Fig. 4).
DISCUSSION
In this study, after contusive SCI, proliferation of as-
trocytes takes place in the hippocampus, and apoptotic 
cell death of motor neurons occurs in the motor cortex. 
In addition, the data showed significant upregulation of 
BDNF, GDNF, and HDAC1 expression. 
Mature NTs induce cell survival upon binding to Trk 
receptors and their immature pro-protein counterparts 
promote apoptosis via activating p75NTR in the spinal 
cord [15]. In accordance with these reports, PC enzymes 
functioning within regulated secretory pathway of neu-
rons and neuroendocrine cells are significantly down-
regulated in the spinal cord after SCI [16]. In contrast, the 
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Fig. 2. HDAC1 and MeCP2 expres-
sion by Western blotting analysis. 
(A) Representative expressions of 
HDAC1 and MeCP2 in the brain 
after contusion of the spinal cord 
in mice. (B) The difference in the 
HDAC1 level between the SCI and 
control groups was significant at 1 
week after SCI (*p<0.05). (C) The 
difference in the MeCP2 level be-
tween the SCI and control groups 
after SCI was not significant. Data 
are plotted as mean±standard er-
ror of the mean. HDAC1, histone 
deacetylase 1; MeCP2, methyl-
CpG-binding protein 2. *p<0.05 
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expression of pro-NGF and pro-NT3 regulating enzymes 
is ubiquitous and pro-BDNF is the primary regulator of 
the secretory pathway of neurons in the spinal cord after 
SCI [17,18]. BDNF has been reported to be an important 
upstream regulator of long-term potentiation in various 
brain regions, including the hippocampus and neocor-
tex [19]. Moreover, previous findings suggested down-
regulation of Nogo receptor and upregulation of BDNF 
linked to plasticity events in the somatosensory cortex 
after SCI [20]. One of the novel findings of our study is 
the significant elevation of BDNF expression at 2 weeks 
and elevation of GDNF expression at 3 days in the cortex 
and hippocampus after SCI. These findings suggest that 
BDNF and GDNF play an important role in astrocyte and 
neuronal reorganization in the brain after SCI.
Several HDACs are expressed at a high level in the 
brain, but their role in brain reorganization has not been 
fully explored. The action of HDACs is opposed by his-
tone acetyltransferases (HATs) such as CREB-binding 
protein and p300, which catalyze the transfer of an acetyl 
moiety from acetyl-coenzyme A to specific lysine resi-
dues of histones [12]. Acetylation of histones alters the 
chromatin structure to a state that is transcriptionally ac-
tive, while histone deacetylation transforms chromatin to 
a transcriptionally repressed state. Hence, gene expres-
sion is regulated, in part, by the balance of HDAC and 
HAT activities [12]. A recent study showed that neuronal 
apoptosis induced by HDAC inhibitors involves stimula-
tion of E2F-1, a transcription factor with established pro-
apoptotic activity in neurons [11]. Histone deacetylase-
related protein expression is downregulated in apoptotic 
neurons, and this occurs prior to the time at which these 
neurons become irreversibly committed to death [11]. 
We hypothesized that neuronal cell loss in the brain 
after SCI is associated with the activity of HDAC1. Our 
data showed significant elevation of HDAC1 level at week 
1 in the brain after SCI. To our knowledge, this is the first 
report that elevation of HDAC1 can be an important epi-
Fig. 3. Spinal cord injury (SCI) reduces the number of surviving neurons in the M1 and M2 areas. SCI resulted in sig-
nificant neuronal cell loss in the M1 and M2 areas at 1 and 2 weeks after injury. (A) Schematic representation of a 
coronal atlas section of rodent brain corresponding to bregma 1.10 mm. (B) Representative findings of NeuN+ staining 
in the coronal sections passing through the rostral and caudal parts of the M1 and M2 areas at 1 and 2 weeks after SCI. 
(C) Higher magnification images of NeuN+ cells in the M1 and M2 areas. (D) The number of NeuN+ cells in the M1 and 
M2 areas. The total number of NeuN+ cells of the lesioned M1 and M2 areas were significantly lower in the SCI group 
(*p<0.05). Scale bar represents 500 μm in (B) and 50 μm in (C). *p<0.05 indicates values significantly different from 
those of the SCI and control groups.
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genetic regulator of neuron apoptosis. However, further 
research is needed to clarify the inhibition of epigenetic 
regulators and neurotrophic factors in the brain after SCI.
Recent studies suggest that retrograde degeneration oc-
curs in the spinal cord of SCI patients, and the anatomi-
cal changes of the supraspinal central nervous system 
were clarified [21]. For example, a recent study found 
in living humans that complete SCI causes anatomical 
changes in the motor cortex, descending pathways from 
the motor cortex and anatomical alterations in areas of 
the brain cortex not directly related to motor control; 
i.e., the cingulated and medial prefrontal cortices [22]. 
Furthermore, alteration in the density and morphology 
of dendritic spines underlies reorganization of synaptic 
connectivity in the motor cortex after SCI [23]. In this 
study, motor neuronal cell loss in the M1 and M2 motor 
cortices was confirmed. Also, surprisingly astrocyte pro-
liferation in the hippocampus was shown. Our study has 
great significance in that, among the supporting neuronal 
cells, the importance of the level of astrocytes after SCI 
was identified. To our knowledge, this is the first report of 
the reorganization of astrocytes. 
Although NGF expression was elevated at 1 and 2 weeks 
after SCI, the difference was not significant. Also, MeCP2 
expression was not significantly different in the SCI group 
compared to the control group. These results suggest that 
NGF and MeCP2 likely have little connection with the 
neuronal reorganization in the brain after SCI. 
The subject of this study was the change patterns in 
the brain after SCI, which is of increasing interest. Brain 
reorganization after SCI is not simply a progressive phe-
nomenon, but instead involves several temporal phases. 
Animal and human studies have suggested a relationship 
between early and late brain reorganization [24]. The 
results of our study suggest that upregulation of BDNF 
at 2 weeks, GDNF at 3 days and 1 week and HDAC1 at 1 
week are associated with increased astrocyte activity and 
a neuroprotective mechanism that enhances survival and 
maintenance of deprived neurons and neuronal circuits 
in the early phase.
The limitation of this study is that the changes in as-
trocytes were not evaluated in various parts of the brain, 
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Fig. 4. Spinal cord injury (SCI) increases the number of surviving astrocytes in the hippocampus. (A) Representative 
findings of GFAP staining in the coronal sections passing through the rostral and caudal parts of the hippocampus at 1 
and 2 weeks after SCI. (B) The number of GFAP+ cells in the hippocampus. The total number of GFAP+ cells was signifi-
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such as the cerebellum, thalamus and other cortices. 
Also, it was a preliminary study of 2-week duration, which 
enabled evaluation of the findings only at the acute and 
subacute phases.
In the future, modifications, such as extending the tem-
poral window or histological analysis of proteins, may be 
needed to clarify the major protein in the brain after SCI. 
We plan to explore the pattern of changes of astrocytes 
in different parts of the brain and evaluate the chronic 
phase to investigate time-dependent change patterns 
(phasic or serial). Moreover, research on knockdown of 
regulators, such as HDAC1, should be pursued to clarify 
the astrocyte proliferation and neuronal apoptosis in the 
brain after SCI. The additional information may help to 
determine whether the neurodegeneration after SCI can 
be stopped, and will hopefully contribute to clinical re-
covery, such as pain control and spasticity management.
In conclusion, our results indicate that upregulation of 
BDNF, GDNF, and epigenetic regulators of HDAC1 might 
play an important role in the structural pathophysiology 
after SCI, especially in terms of neurons and astrocytes in 
the brain.
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